Previous Close | 128.44 |
Open | 128.75 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 128.38 - 131.21 |
52 Week Range | 119.59 - 148.62 |
Volume | |
Avg. Volume | 1,051,595 |
Market Cap | 14.447B |
Beta (5Y Monthly) | 0.89 |
PE Ratio (TTM) | 17.37 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.00 (2.31%) |
Ex-Dividend Date | Apr 05, 2024 |
1y Target Est | N/A |
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Quest Diagnostics (DGX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.